Tomar et al., 2023 - Google Patents
Liquid biopsy and its significance in tumour–Detection in the field of pathologyTomar et al., 2023
View HTML- Document ID
- 1291329599050863158
- Author
- Tomar U
- Grover N
- Tomar S
- Bhalla K
- Singh S
- Publication year
- Publication venue
- Journal of Oral and Maxillofacial Pathology
External Links
Snippet
The treatment of cancer has remarkably improved because of increased knowledge of the abnormalities at the molecular level, which results in human cancer growth. This has initiated the development of ever more successful as well as effective targeted cancer …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Roy et al. | Diagnostic power of DNA methylation classifiers for early detection of cancer | |
| Marrugo-Ramírez et al. | Blood-based cancer biomarkers in liquid biopsy: a promising non-invasive alternative to tissue biopsy | |
| Adhit et al. | Liquid biopsy: an evolving paradigm for non-invasive disease diagnosis and monitoring in medicine | |
| Kalinich et al. | An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma | |
| Huerta et al. | Circulating tumor DNA detection by digital-droplet PCR in pancreatic ductal adenocarcinoma: a systematic review | |
| Malapelle et al. | Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients | |
| Nagpal et al. | Tumor markers: A diagnostic tool | |
| Morey et al. | Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation | |
| Sun et al. | The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma: A meta-analysis | |
| Tomar et al. | Liquid biopsy and its significance in tumour–Detection in the field of pathology | |
| Bronkhorst et al. | Comparison of methods for the isolation of cell-free DNA from cell culture supernatant | |
| TWI833715B (en) | Devices, systems and methods for ultra-low volume liquid biopsy | |
| Maass et al. | From sampling to sequencing: a liquid biopsy pre-analytic workflow to maximize multi-layer genomic information from a single tube | |
| Uguen et al. | A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day | |
| Cappelletti et al. | Analysis of single circulating tumor cells in renal cell carcinoma reveals phenotypic heterogeneity and genomic alterations related to progression | |
| KR20220004645A (en) | Optimized Ultra-Low Volume Liquid Biopsy Methods, Systems and Devices | |
| Berghmans et al. | Implementation of MALDI mass spectrometry imaging in cancer proteomics research: Applications and challenges | |
| Munteanu et al. | MiRNA-based inspired approach in diagnosis of prostate cancer | |
| Cantara et al. | Molecular signature of indeterminate thyroid lesions: current methods to improve fine needle aspiration cytology (FNAC) diagnosis | |
| Smania | Liquid biopsy for cancer screening, diagnosis, and treatment | |
| Siggillino et al. | Detection of EGFR mutations in plasma cell-free tumor DNA of TKI-treated advanced-NSCLC patients by three methodologies: Scorpion-ARMS, PNAClamp, and digital PCR | |
| Spratt | Are we inadvertently widening the disparity gap in pursuit of precision oncology? | |
| Shaw et al. | Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer | |
| Murlidhar et al. | Optimizing the detection of circulating markers to aid in early lung cancer detection | |
| Kataria et al. | Leveraging circulating microbial DNA for early cancer detection |